Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

TechnologyAdvice

- PMLiVE

BMS partners with Simcere to market arthritis drug Orencia SC in China

Builds on existing cancer/ cholesterol alliance between pharma companies

- PMLiVE

Roche’s Avastin gains Japanese approval for brain cancer

Marks drug's first approval to treat newly diagnosed glioblastoma

Pharmacists take tablets to keep up in new NHS

Pharmacy group Alphega to offer free devices and tailored apps to its UK members

- PMLiVE

Icon appoints Dr Neil McCullough to senior compliance role

He joins the clinical research organisation from PPD

Experience me: building engagement through experience

Connected brand experiences can drive social conversation and deeper engagement

Mobile cancer game to accelerate search for a cure

Cancer Research UK will this year launch game that will harness 'citizen science'

- PMLiVE

US charity calls for release of diabetes drug data

American Diabetes Association demands review of incretin-based medicines linked to pancreatic cancer

- PMLiVE

FDA clears Amgen’s Xgeva for rare bone condition

US approval provides alternative to surgery for use in giant cell tumour of the bone

- PMLiVE

Partial victory for biotech sector after gene patent ruling

US Supreme Court decides genes can be patented, if synthetically produced

- PMLiVE

Safety fears force Lilly to halt BACE inhibitor trial in Alzheimer’s

Patients experience abnormal liver functions in trial

- PMLiVE

WPP announces global strategic partnership with Twitter

Agreement will enable WPP to integrate Twitter data into its campaign targeting

EU flag

The future of HTA harmonisation in Europe

The variety and variability of European health technology assessment criteria have created a challenging environment for pharma and a need for much greater harmonisation

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links